NPPB and hydrops fetalis: Moreover, in elderly HF patients in the TIME-CHF trial, NT-proBNP-guided therapy resulted in a higher rate of survival and a lower rate of all-cause hospitalization in patients aged 60 to 70 years, but not in patients older than 75 years, by 18 months of follow-up after initial admission [58].